New Report Expects AI to Drive Revenue Management Value in 2025
Model N’s 2025 State of Revenue Report reveals shifts toward the use of generative AI and automation to bolster medtech and high-tech revenue programs.
Packaging for Med Device Companies: EO and CD Considerations
What medical device manufacturers should keep in mind when packaging for chlorine dioxide (CD) versus ethylene oxide (EO).
Nitinol grips prevent slips in Abbott’s heart valve clips
Nitinol is a key material in the heart valve clips that Abbott designed for its TriClip and MitraClip transcatheter edge-to-edge repair (TEER) systems.
How Abbott created its next-gen RF ablation system
Pulsed field ablation (PFA) has generated a great deal of buzz for its potential to reduce complications in procedures for treating atrial fibrillation (AFib). But even as Abbott is developing its Volt PFA system — announcing in January that it kicked off a CE mark clinical trial of Volt — the medtech giant is betting that tried-and-true radiofrequency (RF) ablation can still make a big difference with the right innovations.
Four Bold Predictions for Medtech in 2025: AI Everywhere, Faster Releases, and Rising Risks
Four promising trends that medtech companies should be aware of heading into 2025 to stay ahead of competition.
2024s Memorable Medtech Moments
Five major medical device industry highlights that caught one experts’ eye in 2024.
Researchers develop light-activated bioprinted heart tissue
Cunjiang Yu, a founder professor of electrical and computer engineering, and his group had their work published in Science Advances. The findings outline the bioprinted tissue stimulated by light in an experimental demonstration of the tissue’s use to manipulate a rat’s heart rate.
In an interview with Medical Design & Outsourcing, Nixon discussed the strategy of moving forward with the entire minimally invasive system at once, feedback from those first cases, the latest on Capstan Medical’s regulatory efforts, and an update on the startup’s tricuspid valve technology.
Systems-level thinking is key to success in ablation device product development
Companies developing new surgical energy (ablation) therapies usually treat each “component” separately. One team of mostly electrical and software engineers develops capital hardware, a different team specialized in mechanical engineering of high-volume disposables develops an instrument or catheter, and yet another team (usually with little product development knowledge at all) specifies and tests the performance in tissue or animal models.
Equipment aesthetics: the companies improving mobility aid design
Assistive devices prioritise function over form, but some users have criticised their lack of aesthetic appeal.
Recycling Challenges and Innovations for Medical Plastics
The healthcare sector’s reliance on single-use medical […]
Innovations In Biocompatible Materials For Medical Devices
The latest breakthroughs, current industry trends, and regulatory challenges of biocompatible materials for medical devices and implants.
Under Pressure: Selecting the Right Pump for Cardiac Ablation Devices
A deep dive into cardiac ablation devices and the importance of selecting the right pump for such devices.
Exploring the Requirements for Reliable, High-Performing Elastomeric Medical Components
As medical devices become increasingly specialized and specific, the need for complementary componentry only grows. This critical, life-saving equipment depends on the ultimate in reliability and consistency, and device manufacturers must accept no compromises when sourcing items like latex or thermoplastic tubing, custom dip-molded parts, and more.
This breakthrough for high-resolution disposable endoscopes comes from an unlikely source
Two trends are dictating the evolution of endoscopes: higher quality imaging and a transition to disposable architectures.
Each of these introduce new challenges for system designers. The breakthrough might come from an unlikely source: The automotive industry.
When Models Fail: Bridging the Gap Between Analytical Models and Empirical Data
Neither analytical models nor physical experiments are sufficient on their own. Progress comes from their interplay, each informing and helping to refine the other. We can resolve discrepancies and deepen our understanding of complex systems by embracing an iterative, informed, systematic approach. And get on with the job of designing and developing the medical device that fills needs and improves lives.
Transformative Medical Device Testing
The medical device industry is on the brink of profound transformation, driven by breakthroughs in artificial intelligence (AI), wearables, additive manufacturing (AM), and enhanced cybersecurity. Medical device manufacturers (MDMs) are starting to embrace the integration of automation, digitization, and Internet of Things (IoT) technologies. So far in 2025, testing firms report increased interest in the end-of-life use of reusable devices, human factors testing for instructions for use (IFU), and low-temperature sterilization methods for temperature-sensitive devices.
Incorporating Medical Device Risk Management into QMS Protocol
How to improve current risk management processes, ensur […]
How Early FDA Engagement Can Accelerate Medical Device Approval & Reduce Market Delays
By interacting with FDA as early as medical device conception, and taking advantage of one or more FDA programs, manufacturers can shorten their time to market and significantly reduce expenditures.
From the Editor – FDA’s Final Rule on LDTs Raises Concerns for Personalized Medicine
Arecent report from data and analytics firm GlobalData finds that FDA’s final rule on laboratory developed tests’ (LDT) hampers innovation and puts the future of these devices in limbo. With the FDA’s final rule on LDTs on the horizon, clinical laboratories, manufacturers, and patients have raised concerns about its potential impact on the U.S.
How metal 3D printing is transforming the way surgical tools are made
Application breakthroughs in fields from prosthetics to implants to regenerative medicine owe a lot to recent advances in 3D printing. This technology, also referred to as additive manufacturing, is now able to manage increasingly complex geometries, opening the door to applications such as drug delivery devices and smart surgical tools.
Will Abbott Have a Strong Year for M&A?
During a 4Q23 earnings call, Ford was asked by an analyst about Abbott’s strong balance sheet, which was described as “$20 billion worth of firepower”, and if that would prompt the company to become involved with acquisitions this year.
Join in MedTech World, and communicate with more than 2000 global advanced suppliers.
Media Partner
Exhibitors Inquiries:
Linc Cai
Tel: +86 21 6157 7217
Email: [email protected]
Conference Inquiries:
Rebecca Lv
Tel：+86-21 6157 7279
Email：[email protected]
Visitors Inquiry & Media Cooperation:
Tracy Zhang
Tel： +86 10 6562 3307
Email：[email protected]
X
